Rani Therapeutics Announces Positive Initial Phase 1a Data for RT-114 for the Treatment of Obesity, with Oral Bioavailability Exceeding Matched Subcutaneous Dosing
Go back to Rani Therapeutics Announces Positive Initial Phase 1a Data for RT-114 for the Treatment of Obesity, with Oral Bioavailability Exceeding Matched Subcutaneous Dosing| (NASDAQ: RANI) | Delayed: 0.85 -0.04 (4.49%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.89 | 52 Week High | $ | |||
| Open | $0.87 | 52 Week Low | $ | |||
| Day High | $0.95 | P/E | N/A | |||
| Day Low | $0.84 | EPS | $ | |||
| Volume | 1,443,429 | |||||
